spiradoline has been researched along with bw 373u86 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, JU; Adler, MW; Chen, XH; DeRiel, JK; Geller, EB; Liu-Chen, LY | 1 |
| Ballard, ME; Harmon, AC; Holtzman, SG; White, DA | 1 |
2 other study(ies) available for spiradoline and bw 373u86
| Article | Year |
|---|---|
An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats.
Topics: Analgesia; Analgesics; Analysis of Variance; Animals; Base Sequence; Benzamides; Cerebrospinal Fluid; Endorphins; Injections, Intraventricular; Injections, Subcutaneous; Male; Molecular Sequence Data; Morphine; Oligonucleotides, Antisense; Piperazines; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1995 |
Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.
Topics: Analgesics, Opioid; Animals; Benzamides; Benzomorphans; Discrimination, Psychological; Dose-Response Relationship, Drug; Drinking; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Pain Measurement; Piperazines; Pyrrolidines; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Water Deprivation | 2008 |